US Stock MarketDetailed Quotes
NBTX Nanobiotix
- 5.380
- -0.140-2.54%
Close Apr 17 16:00 ET
- 5.510
- +0.130+2.42%
Post 19:44 ET
253.46MMarket Cap-3000P/E (TTM)
5.620High5.130Low244.47KVolume5.530Open5.520Pre Close1.35MTurnover0.88%Turnover RatioLossP/E (Static)47.11MShares11.00052wk High-4.41P/B149.46MFloat Cap1.75052wk Low--Dividend TTM27.78MShs Float21.550Historical High--Div YieldTTM8.88%Amplitude1.750Historical Low5.529Avg Price1Lot Size
About Nanobiotix Company
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Company Profile
SymbolNBTX
Company NameNanobiotix
Issue Price13.50
Founded2003
CEODr. Laurent Levy
MarketNASDAQ
Employees102
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address60, rue de Wattignies
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75012
Phone33-1-40-26-04-70
Websitehttp://www.nanobiotix.com
Company Executives
- Name
- Position
- Salary
- Anne-Juliette Hermant
- Chief People Officer and Member of the Executive Board
- 486.62K
- Bart Van Rhijn
- Chief Financial Officer and Member of the Executive Board
- 866.64K
- Dr. Laurent Levy
- Chairman of the Executive Board and Principal Executive Officer
- 1.39M
- Anne-Marie Graffin
- Vice Chairman of the Supervisory Board
- 42.00K
- Dr. Gary M. Phillips, M.D.
- Chairman of the Supervisory Board
- 63.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg